166 related articles for article (PubMed ID: 21439431)
1. Determinants of peritoneal membrane function over time.
Davies SJ; Mushahar L; Yu Z; Lambie M
Semin Nephrol; 2011 Mar; 31(2):172-82. PubMed ID: 21439431
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
3. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.
Aguilera A; Yáñez-Mo M; Selgas R; Sánchez-Madrid F; López-Cabrera M
Curr Opin Investig Drugs; 2005 Mar; 6(3):262-8. PubMed ID: 15816502
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-mesenchymal transition of the mesothelial cell--its role in the response of the peritoneum to dialysis.
Selgas R; Bajo A; Jiménez-Heffernan JA; Sánchez-Tomero JA; Del Peso G; Aguilera A; López-Cabrera M
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii2-7. PubMed ID: 16825254
[TBL] [Abstract][Full Text] [Related]
5. [Anatomic-functional correlation of the peritoneal membrane].
del Peso G; Jiménez-Hefferman JA; Bajo MA; Sánchez-Villanueva R; Tabernero A; Aroeira L; Selgas R
Nefrologia; 2008; 28 Suppl 6():11-6. PubMed ID: 18957006
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis.
Mactier RA
Adv Perit Dial; 2000; 16():223-8. PubMed ID: 11045299
[TBL] [Abstract][Full Text] [Related]
7. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal morphological and functional changes associated with platelet-derived growth factor B.
Cina D; Patel P; Bethune JC; Thoma J; Rodriguez-Lecompte JC; Hoff CM; Liu L; Margetts PJ
Nephrol Dial Transplant; 2009 Feb; 24(2):448-57. PubMed ID: 18775895
[TBL] [Abstract][Full Text] [Related]
9. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
La Milia V; Limardo M; Cavalli A; Crepaldi M; Locatelli F
Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
[TBL] [Abstract][Full Text] [Related]
10. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.
Aroeira LS; Aguilera A; Sánchez-Tomero JA; Bajo MA; del Peso G; Jiménez-Heffernan JA; Selgas R; López-Cabrera M
J Am Soc Nephrol; 2007 Jul; 18(7):2004-13. PubMed ID: 17568021
[TBL] [Abstract][Full Text] [Related]
11. Biocompatible peritoneal dialysis solutions: do we have one?
Chaudhary K; Khanna R
Clin J Am Soc Nephrol; 2010 Apr; 5(4):723-32. PubMed ID: 20093342
[TBL] [Abstract][Full Text] [Related]
12. Morpho-functional study of peritoneum in peritoneal dialysis patients.
Bertoli SV; Buzzi L; Ciurlino D; Maccario M; Martino S
J Nephrol; 2003; 16(3):373-8. PubMed ID: 12832736
[TBL] [Abstract][Full Text] [Related]
13. [Morpho-functional study of peritoneum in peritoneal dialysis].
Bertoli SV; Buzzi L; Ciurlino D; Maccario M; Martino S
G Ital Nefrol; 2003; 20(2):160-5. PubMed ID: 12746801
[TBL] [Abstract][Full Text] [Related]
14. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
[TBL] [Abstract][Full Text] [Related]
15. Changes in peritoneal mesothelial cells phenotype after chronic exposure to glucose or N-acetylglucosamine.
Ciszewicz M; Wu G; Tam P; Polubinska A; Breborowicz A
Transl Res; 2007 Dec; 150(6):337-42. PubMed ID: 18022595
[TBL] [Abstract][Full Text] [Related]
16. Encapsulating peritoneal sclerosis: what have we learned?
Goodlad C; Brown EA
Semin Nephrol; 2011 Mar; 31(2):183-98. PubMed ID: 21439432
[TBL] [Abstract][Full Text] [Related]
17. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
Park MS
Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
[TBL] [Abstract][Full Text] [Related]
18. [Peritoneum as a dialysis membrane. II. Pathology].
Grzybowski A; Breborowicz A
Przegl Lek; 1997; 54(1):52-61. PubMed ID: 9190636
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor.
del Peso G; Fernández-Reyes MJ; Hevia C; Bajo MA; Castro MJ; Cirugeda A; Sánchez-Tomero JA; Selgas R
Nephrol Dial Transplant; 2005 Jun; 20(6):1201-6. PubMed ID: 15827050
[TBL] [Abstract][Full Text] [Related]
20. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]